EDITORIAL
Published on 31 Oct 2023
Editorial: Non-insulin hypoglycemic drugs in type 2 diabetes remission
doi 10.3389/fendo.2023.1325071
- 1,016 views
- Frontiers in Endocrinology
- Clinical Diabetes
- Research Topics
- Non-insulin Hypoglycemic Drugs in Type 2 Diabetes Remission
Non-insulin Hypoglycemic Drugs in Type 2 Diabetes Remission
9,625
Total downloads
32k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
SYSTEMATIC REVIEW
Published on 16 Oct 2023
Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes and obesity: a systematic review and meta-analysis
doi 10.3389/fendo.2023.1214334
- 19,432 views
- 10 citations
REVIEW
Published on 04 Sep 2023
Research progress of dihydromyricetin in the treatment of diabetes mellitus
doi 10.3389/fendo.2023.1216907
- 2,610 views
- 3 citations
REVIEW
Published on 20 Jul 2023
Comprehensive review of SGLT2 inhibitors’ efficacy through their diuretic mode of action in diabetic patients
doi 10.3389/fendo.2023.1174692
- 5,655 views
- 7 citations
SYSTEMATIC REVIEW
Published on 08 May 2023
Efficacy and safety of traditional Chinese medicines combined with conventional Western medicines in the treatment of type 2 diabetes mellitus: a network meta-analysis of randomized controlled trials
doi 10.3389/fendo.2023.1134297
- 2,867 views
- 3 citations
OPINION
Published on 03 Apr 2023
Remission of type 2 diabetes: A critical appraisal
doi 10.3389/fendo.2023.1125961
- 6,941 views
- 2 citations
ORIGINAL RESEARCH
Published on 12 Sep 2022
Long-term remission of type 2 diabetes after very-low-calorie restriction and related predictors
doi 10.3389/fendo.2022.968239
- 4,189 views
- 14 citations
Published in
Frontiers in Endocrinology
- Clinical Diabetes
Impact
- 32kTopic views
- 22kArticle views
- 9,625Article downloads